8/11/22: Issue #13

Issue #13

August 11, 2022

August 11, 2022 | Issue #13

Good evening.

Welcome to the

50-plus

new subscribers who have joined Spannr since our last issue. We're glad you've joined us on our mission to fuel the evolving longevity ecosystem.

In this week's newsletter:

🍄 Aging with Psychedelics

📈 Earnings Season

💰 Funding Roundup

📌 Index Tracker

A Psychedelic Nexus: Veterans, PTSD, and Longevity

Long seen as a quest for the Fountain of Youth, longevity studies have been somewhat mischaracterized.Instead of strictly focusing on pure life extension, longevity also focuses on the more immediately-achievable goals of curbing the worst effects of aging – cognitive and physical decline, emotional and personality changes, and an increase in depressive states.This is important because as people age, they tend to have declines in executive function that can not only lead to depression but can cause withdrawal emotionally. Typically self-perpetuating, they tend to isolate themselves from people and experiences that could cause them to open back up to the world. Perhaps, as detailed in our latest research, this is exactly where psychedelics can play a key, contributing role in the field of geroscience.As more physicians, scientists, and researchers investigate the beneficial effects of psychedelic medical applications on the mind, the more advancements they uncover for the body— specifically, psychedelic treatments' effects on blunting aging and contributing to longevity. Continue Reading >>

It's officially Earnings Season. This means we get to learn a little bit more about the latest business developments, financials, and drug pipelines concerning the public companies at the frontier of longevity biotech. Links to each earnings announcement can be found below...

More business news, reactions, and commentary can be found on each public company page listed here... 

  • Vital, an API for digital health companies, raises $2.9 million seed round led by Point Nine

  • Insilico tops off recent $60 million Series D with another $35 million from Aramco's Prosperity7 Ventures

  • ApoptoSENS Project secures $253,000 in funding from VitaDAO

📌 Reminder...

Late last week, we announced the launch of the Spannr Longevity Stock Index, designed to simplify and clarify the public longevity sector.Our index consists of US-listed, publicly-traded companies that are explicitly focused on aging or aim to extend healthy human lifespans (more details here).That said, now we get the chance to monitor the performance of these longevity stocks on a week-by-week basis. Below is a glimpse of what that will look like in this letter going forward. 👇👇

Spannr Longevity Index Snapshot:

Weekly Performance:

Latest Price: $140.517d-Return: +10.54%Market Cap: $11.98b

Key Drivers:

Denali (DNLI): +15.21%Recursion (RXRX): +16.77%Alector (ALEC): +11.74%